Clinical trial Recruiting at 2 sites Interventional Ages 18 to 40 Women only

Feasibility of a 10-week self-guided digital program for functional hypothalamic amenorrhea

Official title: Feasibility and Acceptability of a Digital Psychoeducational Self-help Program for Women With Functional Hypothalamic Amenorrhea: a Single-arm Pilot Study (HEAL-FHA Pilot)

Run by Karolinska Institutet · NCT07589868 · Data updated 2026-11-12

This pilot test checks whether a 10-week, self-guided web program for FHA is doable and acceptable for women, to pave the way for a larger trial.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment15 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations2 sites (Stockholm, Stockholm County and 1 other locations)
StatusRecruiting
StartedNovember 2, 2026
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07589868 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18-40 with gynecologist-verified FHA (hypogonadotropic hypogonadism), fluent in Swedish, with internet access and BankID.

Probably not a fit

Women with other causes of amenorrhea (pregnancy, thyroid disease, hyperprolactinemia, PCOS), or those with severe psychiatric conditions or eating disorders requiring more intensive care, may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm feasibility study of a 10-week, web-based psychoeducational program designed for women with functional hypothalamic amenorrhea. The intervention is delivered remotely through a secure platform with weekly modules that cover energy balance, stress, nutrition, physical activity, and wellbeing, without therapist support. Participants are recruited from gynecology clinics and confirmed to have FHA using clinical evaluation and hormonal assessment, then complete assessments at baseline, after 10 weeks, and 4 and 8 weeks post-intervention. The study aims to determine feasibility and acceptability, rather than clinical efficacy, in preparation for a future randomized trial. Data include clinical, hormonal, and DIAMOND psychiatric interviews, plus self-report measures to track changes over time.

Why it matters

Potential benefit: If successful, the program could offer a scalable, accessible option to help manage FHA by improving energy balance and well‑being.

How similar studies have gone: Prior digital or self-guided interventions for FHA or related hormone-function issues have shown feasibility in pilot formats, but this specific 10-week self-guided platform is novel in its fully remote, therapist-free design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Women aged 18-40 years with functional hypothalamic amenorrhea (hypogonadotropic hypogonadism) verified by a gynecologist; able to read and understand Swedish; access to an internet-enabled device and BankID; written informed consent.

Exclusion Criteria:

Current anorexia nervosa, bulimia nervosa or binge-eating disorder according to the DIAMOND structured diagnostic interview (other specified feeding or eating disorder is not an exclusion criterion); severe psychiatric comorbidity requiring other or more intensive care, including psychosis; insufficient Swedish proficiency; other causes of amenorrhea, including pregnancy, thyroid disease, hyperprolactinemia and polycystic ovary syndrome.

Where it's running

  • Women's Health Clinic, Karolinska University Hospital
    Stockholm, Stockholm County, Sweden
    Recruiting
  • Karolinska University Hospital
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.